Is Recurrent Venous Thromboembolism After Therapy Reduced by Low-Molecular-Weight Heparin Compared With Oral Anticoagulants?G. Ferretti, F. Cognetti, Fabiana Letizia Cecere et al.|CHEST Journal|2006Cited by 41
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trialsFederica Cuppone, Francesco Cognetti, Emilio Bria et al.|Journal of Experimental & Clinical Cancer Research|2011Cited by 31
Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trialsFederica Cuppone, Paolo Carlini|BMC Cancer|2010Cited by 23
Aromatase inhibitors in post-menopausal metastatic breast carcinomaPaolo Carlini, G. Ferretti, Emilio Bria et al.|Expert Opinion on Investigational Drugs|2007Cited by 5
Maintenance bevacizumab after first-line treatment in HER2-negative metastatic breast cancer patients.Alessandra Fabi, F. Cognetti, Michelangelo Russillo et al.|Journal of Clinical Oncology|2011Cited by 0